Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation.
Saved in:
| Title: | Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation. |
|---|---|
| Authors: | Hsieh, Pei-Ling1 (AUTHOR), Chu, Pei-Ming2 (AUTHOR), Cheng, Hui-Ching3 (AUTHOR), Huang, Yu-Ting3 (AUTHOR), Chou, Wan-Ching3 (AUTHOR), Tsai, Kun-Ling3,4 (AUTHOR) kunlingtsai@mail.ncku.edu.tw, Chan, Shih-Hung5 (AUTHOR) kunlingtsai@mail.ncku.edu.tw |
| Source: | International Journal of Molecular Sciences. Sep2022, Vol. 23 Issue 17, p10146. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16616596 |
|---|---|
| DOI: | 10.3390/ijms231710146 |